Here are relevant reports on : peptide-synthesis-market

• Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-phase, Solution-phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029

  The global peptide synthesis market, valued at US$0.78 billion in 2023, stood at US$0.81 billion in 2024 and is projected to advance at a resilient CAGR of 11.7% from 2024 to 2029, culminating in a forecasted valuation of US$1.41 billion by the end of the period. The peptide synthesis market is driven by the growing demand for therapeutic peptides in treating chronic diseases, including cancer, diabetes, and cardiovascular disorders.

  • Published: February 2025
  • Price: $ 4950
  • TOC Available:

• Natural Vanillin Market by Source (Vanilla Bean Extract, Ferulic Acid Synthesis, and Eugenol Synthesis), Application (Food & Beverages, Pharmaceuticals, and Cosmetics & Personal Care), Form, and Region-Global Forecast to 2027

  The global natural vanillin market is projected to reach USD 706 million by 2027, growing at a CAGR of 8.4% during the forecast period. The key players in the natural vanillin market include Givaudan (Switzerland), Firmenich SA (Switzerland), Symrise (Germany), Kerry Group plc (Ireland), Solvay (Belgium), International Flavors and Fragrances (US), Sensient Technologies Corporation (US), McCormick & Company, Inc. (US), Mane (France), and Lesaffre (France).

  • Published: February 2023
  • Price: $ 4950
  • TOC Available:

• mRNA Synthesis & Manufacturing Market by Product (Consumables (Transcription, Purification, Analysis & Characterization), Instrument), Service (Synthesis, Purification, Manufacturing & Scale-up), Application (CGT, Vaccines) - Global Forecast to 2029

  The global mRNA synthesis & manufacturing market, valued at US$2.22 billion in 2023, stood at US$2.23 billion in 2024 and is projected to advance at a resilient CAGR of 5.8% from 2024 to 2029, culminating in a forecasted valuation of US$2.96 billion by the end of the period. The primary drivers behind the expansion of this industry are the Growing focus on mRNA-based vaccine development, expanding therapeutic applications of mRNA technology, advancements in mRNA synthesis technology, increased outsourcing for mRNA synthesis and modification, and collaborations among industry players.

  • Published: January 2025
  • Price: $ 4950
  • TOC Available:

• Oligonucleotide Synthesis Market by Offerings (Synthesis products [Consumables, Equipment], Synthesized Oligos (Type [DNA, RNA], Oligo-based Drugs (Type [ASO, siRNA), Therapy Area [Rare Diseases, Neurology, Oncology], Competition - Global Forecast to 2031

  The global oligonucleotide synthesis market is projected to reach USD 32.72 billion by 2031, growing at a CAGR of 17.4% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.

  • Published: July 2026
  • Price: $ 4950
  • TOC Available:

• Next Generation Drug Conjugates Market by Product (Enhertu, Amvuttra), Type (Antibody-Small Molecule), Target Ligand (Antibody, Peptide), Payload Type (Oligonucleotide, Radionuclide), Indication (Breast Cancer, Prostate Cancer) - Global Forecast to 2035

  The global Next-generation drug conjugates (NDCs) market is projected to reach USD 42.55 billion by 2035, growing at a CAGR of 11.7% during the forecast period (2026–2035). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.

  • Published: April 2026
  • Price: $ 4950
  • TOC Available:

• RNAi & Peptide-Based Pesticides Market by Crop Type (Fruits & Vegetables, Cereals & Grains, Oilseed & Pulses, Other Crop Types) And Region (North America, Europe, South America, Rest Of The World) - Global Forecast to 2030

  According to MarketsandMarkets, the global market for RNAi-based pesticides is estimated at USD XX million in 2024 and is projected to reach USD XXX.X million by 2030, at a high CAGR of 90%, while the Peptide-based pesticides market is estimated at USD XX.X million in 2024 and is projected to reach USD XXX.X million by 2030, at a double-digit CAGR of 66.8% during the forecast period. The peptide-based pesticides market is dominated by companies such as Vestaron Corporation (US), Innatrix, Inc. (US), Elemental Enzymes (US), Solasta Bio (UK), Micropep (France), Invaio Sciences (US), and Genvor Incorporated (US). As a market pioneer, Vestaron's SPEAR® brand highlights its peptide technology, offering a distinct mode of action compared to traditional synthetic pesticides.

  • Published: September 2026
  • Price: $ 4950
  • TOC Available:

• Biosimulation Market by Phase (Drug Discovery, Preclinical, Regulatory), Modality (Antibody, Peptide), Application (Molecular Design, PK/PD, QSP, Trial Simulation, Disease Modeling), Indication (Cardio, Onco), End User (CRO, Pharma) – Global Forecast to 2031

  The global biosimulation market is projected to reach USD 9.24 billion by 2031, growing at a CAGR of 16.7% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.

  • Published: June 2026
  • Price: $ 4950
  • TOC Available:

• Active Pharmaceutical Ingredients (API) Market by type (Innovative, Generic), Synthesis (synthetic, biotech), Potency (HPAPI), Product (mAbs, hormones), Drug (OTC, Rx), Application (Diabetes, Oncology), Competitive landscape - Global forecast to 2030

  The global active pharmaceutical ingredient market, valued at US$136.22 billion in 2024, stood at US$144.20 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2024 to 2030, culminating in a forecasted valuation of US$198.39 billion by the end of the period. The growth of the active pharmaceutical ingredients market is driven by the surge in demand for complex APIs, such as high-potency API, peptides, oligonucleotides, and increasing government incentives and supply chain reshoring.

  • Published: October 2025
  • Price: $ 4950
  • TOC Available:

• Sugar Substitutes Market by Type (HFCS, High-intensity Sweeteners, Low-Intensity Sweeteners), Manufacturing Technology (Precision Fermentation, Enzymatic Conversion, Chemical Synthesis), Application, Form, Source, Region - Global Forecast to 2029

  The sugar substitutes market is projected to reach USD 29.90 billion by 2029, at a CAGR of 4.9% during the forecast period. The report profiles key players such as Cargill, Incorporated (US), ADM (US), Ingredion (US), International Flavors & Fragrances Inc (US), Tate & Lyle (UK), Ajinomoto Co. Inc (Japan), GLG Life Tech Corp (Canada), Celanese Corporation (US), Roquette Frères (France), PCIPL (India), Mane SA. (France), Döhler GmbH (Germany), Morita Kagaku Kogyo Co., Ltd (Japan), zuChem (US), and Van Wankum Ingredients (Netherlands).

  • Published: October 2024
  • Price: $ 4950
  • TOC Available:

• Europe Oligonucleotide Synthesis Market by Product (Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment), Application (Therapeutic, Research, Diagnostics) - Forecast to 2030

  The Europe Oligonucleotide Synthesis market, valued at USD 2.68 billion in 2024, stood at USD 3.17 billion in 2025 and is projected to advance at a resilient CAGR of 18.7% from 2025 to 2030, culminating in a forecasted valuation of USD 7.49 billion by the end of the period. The market is growing due to strong demand from therapeutics, diagnostics, and research.

  • Published: August 2026
  • Price: $ 4950
  • TOC Available:

• NEXT
• LAST

Records 1 to 10 of 50